These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2662577)

  • 1. Enzyme processing of La Crosse virus glycoprotein G1: a bunyavirus-vector infection model.
    Ludwig GV; Christensen BM; Yuill TM; Schultz KT
    Virology; 1989 Jul; 171(1):108-13. PubMed ID: 2662577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of La Crosse virus glycoproteins in attachment of virus to host cells.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Virology; 1991 Apr; 181(2):564-71. PubMed ID: 1673039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recently introduced Aedes albopictus in the United States: potential vector of La Crosse virus (Bunyaviridae: California serogroup).
    Grimstad PR; Kobayashi JF; Zhang MB; Craig GB
    J Am Mosq Control Assoc; 1989 Sep; 5(3):422-7. PubMed ID: 2584976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.
    Sundin DR; Beaty BJ; Nathanson N; Gonzalez-Scarano F
    Science; 1987 Jan; 235(4788):591-3. PubMed ID: 3810159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and localization of conserved antigenic epitopes on the G2 proteins of California serogroup Bunyaviruses.
    Cheng LL; Schultz KT; Yuill TM; Israel BA
    Viral Immunol; 2000; 13(2):201-13. PubMed ID: 10893000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
    Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
    J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
    Schuh T; Schultz J; Moelling K; Pavlovic J
    Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.
    Gonzalez-Scarano F; Janssen RS; Najjar JA; Pobjecky N; Nathanson N
    J Virol; 1985 Jun; 54(3):757-63. PubMed ID: 3889368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
    Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
    Virol J; 2007 May; 4():41. PubMed ID: 17488515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication and dissemination of La Crosse virus in the competent vector Aedes triseriatus and the incompetent vector Aedes hendersoni and evidence for transovarial transmission by Aedes hendersoni (Diptera: Culicidae).
    Paulson SL; Grimstad PR
    J Med Entomol; 1989 Nov; 26(6):602-9. PubMed ID: 2585454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodmeal sources of Aedes triseriatus and Aedes vexans in a southern Wisconsin forest endemic for La Crosse encephalitis virus.
    Burkot TR; DeFoliart GR
    Am J Trop Med Hyg; 1982 Mar; 31(2):376-81. PubMed ID: 7072901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. La Crosse virus infection of mammalian cells induces mRNA instability.
    Raju R; Kolakofsky D
    J Virol; 1988 Jan; 62(1):27-32. PubMed ID: 3334745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup.
    Pekosz A; Griot C; Nathanson N; Gonzalez-Scarano F
    Virology; 1995 Dec; 214(2):339-48. PubMed ID: 8553534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of La Crosse virus replication by monensin, monovalent ionophore.
    Cash P
    J Gen Virol; 1982 Mar; 59(Pt 1):193-6. PubMed ID: 7069403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
    Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
    J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M viral RNA segment of bunyaviruses codes for two glycoproteins, G1 and G2.
    Gentsch JR; Bishop DL
    J Virol; 1979 Jun; 30(3):767-70. PubMed ID: 480466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.